 | • レポートコード：QAF27580 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアトロピン市場について種類別（注射、ドロップ、ジェル）、用途別（胃腸、眼科、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アトロピン市場の概要 ・世界の主要地域別アトロピン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアトロピン市場規模2016-2021：種類別（注射、ドロップ、ジェル） ・世界のアトロピン市場予測2012-2027：種類別（注射、ドロップ、ジェル） ・世界のアトロピン市場規模2016-2021：用途別（胃腸、眼科、その他） ・世界のアトロピン市場予測2012-2027：用途別（胃腸、眼科、その他） ・アトロピンのアメリカ市場規模と予測2016-2021 ・アトロピンのヨーロッパ市場規模と予測2016-2021 ・アトロピンの中国市場規模と予測2016-2021 ・アトロピンの日本市場規模と予測2016-2021 ・アトロピンの東南アジア市場規模と予測2016-2021 ・アトロピンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （C²PHARMA、RESONANCE LABORATORIES、ROLABO OUTSOURCING、Minsheng、CR Double-Crane、HENAN PURUI、Albany Molecular Research、Alchem International、SAURAV CHEMICALS、Katsura Chemical、Hangzhou Vega、Wuhan senwayer century） ・アトロピンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・アトロピンの市場動向・機会・課題 ・調査の結論 |
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng and CR Double-Crane.
As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of long-term effects of market behavior.
The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.
Market Analysis and Insights: Global Atropine Market
The global Atropine market was valued at US$ 511.6 in 2020 and will reach US$ 461.6 million by the end of 2027, growing at a CAGR of -1.7% during 2022-2027.
Global Atropine Scope and Market Size
The global Atropine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atropine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
The Atropine market is analysed and market size information is provided by regions (countries). Segment by Application, the Atropine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
1 Atropine Market Overview
1.1 Atropine Product Scope
1.2 Atropine Segment by Type
1.2.1 Global Atropine Sales by Type (2016 & 2021 & 2027)
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine Segment by Application
1.3.1 Global Atropine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Atropine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Atropine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Atropine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Atropine Price Trends (2016-2027)
2 Atropine Estimates and Forecasts by Region
2.1 Global Atropine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Atropine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Atropine Sales Market Share by Region (2016-2021)
2.2.2 Global Atropine Revenue Market Share by Region (2016-2021)
2.3 Global Atropine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Atropine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Atropine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Atropine Estimates and Projections (2016-2027)
2.4.2 Europe Atropine Estimates and Projections (2016-2027)
2.4.3 China Atropine Estimates and Projections (2016-2027)
2.4.4 Japan Atropine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Atropine Estimates and Projections (2016-2027)
2.4.6 India Atropine Estimates and Projections (2016-2027)
3 Global Atropine Competition Landscape by Players
3.1 Global Top Atropine Players by Sales (2016-2021)
3.2 Global Top Atropine Players by Revenue (2016-2021)
3.3 Global Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atropine as of 2020)
3.4 Global Atropine Average Price by Company (2016-2021)
3.5 Manufacturers Atropine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Atropine Market Size by Type
4.1 Global Atropine Historic Market Review by Type (2016-2021)
4.1.1 Global Atropine Sales Market Share by Type (2016-2021)
4.1.2 Global Atropine Revenue Market Share by Type (2016-2021)
4.1.3 Global Atropine Price by Type (2016-2021)
4.2 Global Atropine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Atropine Sales Forecast by Type (2022-2027)
4.2.2 Global Atropine Revenue Forecast by Type (2022-2027)
4.2.3 Global Atropine Price Forecast by Type (2022-2027)
5 Global Atropine Market Size by Application
5.1 Global Atropine Historic Market Review by Application (2016-2021)
5.1.1 Global Atropine Sales Market Share by Application (2016-2021)
5.1.2 Global Atropine Revenue Market Share by Application (2016-2021)
5.1.3 Global Atropine Price by Application (2016-2021)
5.2 Global Atropine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Atropine Sales Forecast by Application (2022-2027)
5.2.2 Global Atropine Revenue Forecast by Application (2022-2027)
5.2.3 Global Atropine Price Forecast by Application (2022-2027)
6 North America Atropine Market Facts & Figures
6.1 North America Atropine Sales by Company
6.1.1 North America Atropine Sales by Company (2016-2021)
6.1.2 North America Atropine Revenue by Company (2016-2021)
6.2 North America Atropine Sales Breakdown by Type
6.2.1 North America Atropine Sales Breakdown by Type (2016-2021)
6.2.2 North America Atropine Sales Breakdown by Type (2022-2027)
6.3 North America Atropine Sales Breakdown by Application
6.3.1 North America Atropine Sales Breakdown by Application (2016-2021)
6.3.2 North America Atropine Sales Breakdown by Application (2022-2027)
7 Europe Atropine Market Facts & Figures
7.1 Europe Atropine Sales by Company
7.1.1 Europe Atropine Sales by Company (2016-2021)
7.1.2 Europe Atropine Revenue by Company (2016-2021)
7.2 Europe Atropine Sales Breakdown by Type
7.2.1 Europe Atropine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Atropine Sales Breakdown by Type (2022-2027)
7.3 Europe Atropine Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Atropine Market Facts & Figures
8.1 China Atropine Sales by Company
8.1.1 China Atropine Sales by Company (2016-2021)
8.1.2 China Atropine Revenue by Company (2016-2021)
8.2 China Atropine Sales Breakdown by Type
8.2.1 China Atropine Sales Breakdown by Type (2016-2021)
8.2.2 China Atropine Sales Breakdown by Type (2022-2027)
8.3 China Atropine Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Atropine Market Facts & Figures
9.1 Japan Atropine Sales by Company
9.1.1 Japan Atropine Sales by Company (2016-2021)
9.1.2 Japan Atropine Revenue by Company (2016-2021)
9.2 Japan Atropine Sales Breakdown by Type
9.2.1 Japan Atropine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Atropine Sales Breakdown by Type (2022-2027)
9.3 Japan Atropine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Atropine Market Facts & Figures
10.1 Southeast Asia Atropine Sales by Company
10.1.1 Southeast Asia Atropine Sales by Company (2016-2021)
10.1.2 Southeast Asia Atropine Revenue by Company (2016-2021)
10.2 Southeast Asia Atropine Sales Breakdown by Type
10.2.1 Southeast Asia Atropine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Atropine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Atropine Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Atropine Market Facts & Figures
11.1 India Atropine Sales by Company
11.1.1 India Atropine Sales by Company (2016-2021)
11.1.2 India Atropine Revenue by Company (2016-2021)
11.2 India Atropine Sales Breakdown by Type
11.2.1 India Atropine Sales Breakdown by Type (2016-2021)
11.2.2 India Atropine Sales Breakdown by Type (2022-2027)
11.3 India Atropine Sales Breakdown by Application
11.3.1 India Atropine Sales Breakdown by Application (2016-2021)
11.3.2 India Atropine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Atropine Business
12.1 C²PHARMA
12.1.1 C²PHARMA Corporation Information
12.1.2 C²PHARMA Business Overview
12.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 C²PHARMA Atropine Products Offered
12.1.5 C²PHARMA Recent Development
12.2 RESONANCE LABORATORIES
12.2.1 RESONANCE LABORATORIES Corporation Information
12.2.2 RESONANCE LABORATORIES Business Overview
12.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 RESONANCE LABORATORIES Atropine Products Offered
12.2.5 RESONANCE LABORATORIES Recent Development
12.3 ROLABO OUTSOURCING
12.3.1 ROLABO OUTSOURCING Corporation Information
12.3.2 ROLABO OUTSOURCING Business Overview
12.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ROLABO OUTSOURCING Atropine Products Offered
12.3.5 ROLABO OUTSOURCING Recent Development
12.4 Minsheng
12.4.1 Minsheng Corporation Information
12.4.2 Minsheng Business Overview
12.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Minsheng Atropine Products Offered
12.4.5 Minsheng Recent Development
12.5 CR Double-Crane
12.5.1 CR Double-Crane Corporation Information
12.5.2 CR Double-Crane Business Overview
12.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CR Double-Crane Atropine Products Offered
12.5.5 CR Double-Crane Recent Development
12.6 HENAN PURUI
12.6.1 HENAN PURUI Corporation Information
12.6.2 HENAN PURUI Business Overview
12.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HENAN PURUI Atropine Products Offered
12.6.5 HENAN PURUI Recent Development
12.7 Albany Molecular Research
12.7.1 Albany Molecular Research Corporation Information
12.7.2 Albany Molecular Research Business Overview
12.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Albany Molecular Research Atropine Products Offered
12.7.5 Albany Molecular Research Recent Development
12.8 Alchem International
12.8.1 Alchem International Corporation Information
12.8.2 Alchem International Business Overview
12.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Alchem International Atropine Products Offered
12.8.5 Alchem International Recent Development
12.9 SAURAV CHEMICALS
12.9.1 SAURAV CHEMICALS Corporation Information
12.9.2 SAURAV CHEMICALS Business Overview
12.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SAURAV CHEMICALS Atropine Products Offered
12.9.5 SAURAV CHEMICALS Recent Development
12.10 Katsura Chemical
12.10.1 Katsura Chemical Corporation Information
12.10.2 Katsura Chemical Business Overview
12.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Katsura Chemical Atropine Products Offered
12.10.5 Katsura Chemical Recent Development
12.11 Hangzhou Vega
12.11.1 Hangzhou Vega Corporation Information
12.11.2 Hangzhou Vega Business Overview
12.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hangzhou Vega Atropine Products Offered
12.11.5 Hangzhou Vega Recent Development
12.12 Wuhan senwayer century
12.12.1 Wuhan senwayer century Corporation Information
12.12.2 Wuhan senwayer century Business Overview
12.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Wuhan senwayer century Atropine Products Offered
12.12.5 Wuhan senwayer century Recent Development
13 Atropine Manufacturing Cost Analysis
13.1 Atropine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Atropine
13.4 Atropine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Atropine Distributors List
14.3 Atropine Customers
15 Market Dynamics
15.1 Atropine Market Trends
15.2 Atropine Drivers
15.3 Atropine Market Challenges
15.4 Atropine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Atropine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Atropine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Atropine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Atropine Sales (MT) by Region (2016-2021)
Table 5. Global Atropine Sales Market Share by Region (2016-2021)
Table 6. Global Atropine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Atropine Revenue Share by Region (2016-2021)
Table 8. Global Atropine Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Atropine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Atropine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Atropine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Atropine Sales (MT) of Key Companies (2016-2021)
Table 13. Global Atropine Sales Share by Company (2016-2021)
Table 14. Global Atropine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Atropine Revenue Share by Company (2016-2021)
Table 16. Global Atropine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atropine as of 2020)
Table 17. Global Atropine Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Atropine Manufacturing Sites and Area Served
Table 19. Manufacturers Atropine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Atropine Sales (MT) by Type (2016-2021)
Table 22. Global Atropine Sales Share by Type (2016-2021)
Table 23. Global Atropine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Atropine Price (USD/Kg) by Type (2016-2021)
Table 25. Global Atropine Sales Share by Type (2022-2027)
Table 26. Global Atropine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Atropine Revenue Share by Type (2022-2027)
Table 28. Global Atropine Price (USD/Kg) by Type (2022-2027)
Table 29. Global Atropine Sales (MT) by Application (2016-2021)
Table 30. Global Atropine Sales Share by Application (2016-2021)
Table 31. Global Atropine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Atropine Price (USD/Kg) by Application (2016-2021)
Table 33. Global Atropine Sales (MT) by Application (2022-2027)
Table 34. Global Atropine Sales Share by Application (2022-2027)
Table 35. Global Atropine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Atropine Revenue Share by Application (2022-2027)
Table 37. Global Atropine Price (USD/Kg) by Application (2022-2027)
Table 38. North America Atropine Sales (MT) by Company (2016-2021)
Table 39. North America Atropine Sales Market Share by Company (2016-2021)
Table 40. North America Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Atropine Revenue Market Share by Company (2016-2021)
Table 42. North America Atropine Sales by Type (2016-2021) & (MT)
Table 43. North America Atropine Sales Market Share by Type (2016-2021)
Table 44. North America Atropine Sales by Type (2022-2027) & (MT)
Table 45. North America Atropine Sales Market Share by Type (2022-2027)
Table 46. North America Atropine Sales by Application (2016-2021) & (MT)
Table 47. North America Atropine Sales Market Share by Application (2016-2021)
Table 48. North America Atropine Sales by Application (2022-2027) & (MT)
Table 49. North America Atropine Sales Market Share by Application (2022-2027)
Table 50. Europe Atropine Sales (MT) by Company (2016-2021)
Table 51. Europe Atropine Sales Market Share by Company (2016-2021)
Table 52. Europe Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Atropine Revenue Market Share by Company (2016-2021)
Table 54. Europe Atropine Sales by Type (2016-2021) & (MT)
Table 55. Europe Atropine Sales Market Share by Type (2016-2021)
Table 56. Europe Atropine Sales by Type (2022-2027) & (MT)
Table 57. Europe Atropine Sales Market Share by Type (2022-2027)
Table 58. Europe Atropine Sales by Application (2016-2021) & (MT)
Table 59. Europe Atropine Sales Market Share by Application (2016-2021)
Table 60. Europe Atropine Sales by Application (2022-2027) & (MT)
Table 61. Europe Atropine Sales Market Share by Application (2022-2027)
Table 62. China Atropine Sales (MT) by Company (2016-2021)
Table 63. China Atropine Sales Market Share by Company (2016-2021)
Table 64. China Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Atropine Revenue Market Share by Company (2016-2021)
Table 66. China Atropine Sales by Type (2016-2021) & (MT)
Table 67. China Atropine Sales Market Share by Type (2016-2021)
Table 68. China Atropine Sales by Type (2022-2027) & (MT)
Table 69. China Atropine Sales Market Share by Type (2022-2027)
Table 70. China Atropine Sales by Application (2016-2021) & (MT)
Table 71. China Atropine Sales Market Share by Application (2016-2021)
Table 72. China Atropine Sales by Application (2022-2027) & (MT)
Table 73. China Atropine Sales Market Share by Application (2022-2027)
Table 74. Japan Atropine Sales (MT) by Company (2016-2021)
Table 75. Japan Atropine Sales Market Share by Company (2016-2021)
Table 76. Japan Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Atropine Revenue Market Share by Company (2016-2021)
Table 78. Japan Atropine Sales by Type (2016-2021) & (MT)
Table 79. Japan Atropine Sales Market Share by Type (2016-2021)
Table 80. Japan Atropine Sales by Type (2022-2027) & (MT)
Table 81. Japan Atropine Sales Market Share by Type (2022-2027)
Table 82. Japan Atropine Sales by Application (2016-2021) & (MT)
Table 83. Japan Atropine Sales Market Share by Application (2016-2021)
Table 84. Japan Atropine Sales by Application (2022-2027) & (MT)
Table 85. Japan Atropine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Atropine Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Atropine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Atropine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Atropine Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Atropine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Atropine Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Atropine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Atropine Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Atropine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Atropine Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Atropine Sales Market Share by Application (2022-2027)
Table 98. India Atropine Sales (MT) by Company (2016-2021)
Table 99. India Atropine Sales Market Share by Company (2016-2021)
Table 100. India Atropine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Atropine Revenue Market Share by Company (2016-2021)
Table 102. India Atropine Sales by Type (2016-2021) & (MT)
Table 103. India Atropine Sales Market Share by Type (2016-2021)
Table 104. India Atropine Sales by Type (2022-2027) & (MT)
Table 105. India Atropine Sales Market Share by Type (2022-2027)
Table 106. India Atropine Sales by Application (2016-2021) & (MT)
Table 107. India Atropine Sales Market Share by Application (2016-2021)
Table 108. India Atropine Sales by Application (2022-2027) & (MT)
Table 109. India Atropine Sales Market Share by Application (2022-2027)
Table 110. C²PHARMA Corporation Information
Table 111. C²PHARMA Description and Business Overview
Table 112. C²PHARMA Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. C²PHARMA Atropine Product
Table 114. C²PHARMA Recent Development
Table 115. RESONANCE LABORATORIES Corporation Information
Table 116. RESONANCE LABORATORIES Description and Business Overview
Table 117. RESONANCE LABORATORIES Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. RESONANCE LABORATORIES Atropine Product
Table 119. RESONANCE LABORATORIES Recent Development
Table 120. ROLABO OUTSOURCING Corporation Information
Table 121. ROLABO OUTSOURCING Description and Business Overview
Table 122. ROLABO OUTSOURCING Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. ROLABO OUTSOURCING Atropine Product
Table 124. ROLABO OUTSOURCING Recent Development
Table 125. Minsheng Corporation Information
Table 126. Minsheng Description and Business Overview
Table 127. Minsheng Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Minsheng Atropine Product
Table 129. Minsheng Recent Development
Table 130. CR Double-Crane Corporation Information
Table 131. CR Double-Crane Description and Business Overview
Table 132. CR Double-Crane Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. CR Double-Crane Atropine Product
Table 134. CR Double-Crane Recent Development
Table 135. HENAN PURUI Corporation Information
Table 136. HENAN PURUI Description and Business Overview
Table 137. HENAN PURUI Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. HENAN PURUI Atropine Product
Table 139. HENAN PURUI Recent Development
Table 140. Albany Molecular Research Corporation Information
Table 141. Albany Molecular Research Description and Business Overview
Table 142. Albany Molecular Research Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Albany Molecular Research Atropine Product
Table 144. Albany Molecular Research Recent Development
Table 145. Alchem International Corporation Information
Table 146. Alchem International Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Alchem International Description and Business Overview
Table 148. Alchem International Atropine Product
Table 149. Alchem International Recent Development
Table 150. SAURAV CHEMICALS Corporation Information
Table 151. SAURAV CHEMICALS Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. SAURAV CHEMICALS Description and Business Overview
Table 153. SAURAV CHEMICALS Atropine Product
Table 154. SAURAV CHEMICALS Recent Development
Table 155. Katsura Chemical Corporation Information
Table 156. Katsura Chemical Description and Business Overview
Table 157. Katsura Chemical Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Katsura Chemical Atropine Product
Table 159. Katsura Chemical Recent Development
Table 160. Hangzhou Vega Corporation Information
Table 161. Hangzhou Vega Description and Business Overview
Table 162. Hangzhou Vega Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Hangzhou Vega Atropine Product
Table 164. Hangzhou Vega Recent Development
Table 165. Wuhan senwayer century Corporation Information
Table 166. Wuhan senwayer century Description and Business Overview
Table 167. Wuhan senwayer century Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Wuhan senwayer century Atropine Product
Table 169. Wuhan senwayer century Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Atropine Distributors List
Table 173. Atropine Customers List
Table 174. Atropine Market Trends
Table 175. Atropine Market Drivers
Table 176. Atropine Market Challenges
Table 177. Atropine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Atropine Product Picture
Figure 2. Global Atropine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Atropine Sales Market Share by Application in 2021 & 2027
Figure 6. Gastrointestinal Examples
Figure 7. Ophthalmology Examples
Figure 8. Other Examples
Figure 9. Global Atropine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Atropine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Atropine Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Atropine Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 13. Global Atropine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Atropine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Atropine Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Atropine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Atropine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Atropine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Atropine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Atropine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Atropine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Atropine Players Market Share by Revenue in Atropine: 2016 & 2020
Figure 28. Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Atropine Revenue Share by Type (2016-2021)
Figure 30. Global Atropine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Atropine Revenue Share by Application (2016-2021)
Figure 32. Global Atropine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Atropine Sales Market Share by Type in 2020
Figure 34. North America Atropine Sales Market Share by Application in 2020
Figure 35. Europe Atropine Sales Market Share by Type in 2020
Figure 36. Europe Atropine Sales Market Share by Application in 2020
Figure 37. China Atropine Sales Market Share by Type in 2020
Figure 38. China Atropine Sales Market Share by Application in 2020
Figure 39. Japan Atropine Sales Market Share by Type in 2020
Figure 40. Japan Atropine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Atropine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Atropine Sales Market Share by Application in 2020
Figure 43. India Atropine Sales Market Share by Type in 2020
Figure 44. India Atropine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Atropine
Figure 47. Manufacturing Process Analysis of Atropine
Figure 48. Atropine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
硫酸アトロピンのグローバル市場調査 2019年 The global Atropine Sulfate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Atropine Sulfate volume and value at global level, regional level and company level. From a global perspective, this repor…- 世界の吸入麻酔薬市場規模・現状・予測（2021年-2027年） Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circul…
- 注射用ミカファンギンナトリウムのグローバル市場2021 Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 点眼薬のグローバル市場2021 Eye Drop Dispenser is a kind of medical devices, which is used to treat major eye problems and diseases for patients with arthritis, Parkinson and weak hands to use eye drops, especially the elderly person. Patients find difficulty in properly installing drops into eyes due to the result of the inab…
- 下痢を伴う過敏性腸症候群（IBS-D）薬のグローバル市場調査 2019年 The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level,…